Madrigal Pharmaceuticals
MDGL
MDGL
132 hedge funds and large institutions have $1.36B invested in Madrigal Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 12 closing their positions.
Holders
132
Holders Change
+8
Holders Change %
+6.45%
% of All Funds
2.34%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
20
Increased
46
Reduced
41
Closed
12
Calls
$9.07M
Puts
$4.18M
Net Calls
+$4.89M
Net Calls Change
-$5.6M
Top Buyers
| 1 |
ACA
1
Avoro Capital Advisors
New York
|
$136M |
| 2 |
2
BlackRock
New York
|
$105M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$71.5M |
| 4 |
4
Wellington Management Group
Boston,
Massachusetts
|
$102M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$98.8M |
Top Sellers
| 1 |
HM
1
HealthCor Management
New York
|
$100M |
| 2 |
2
AllianceBernstein
Nashville,
Tennessee
|
$37.7M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$799K |
| 4 |
CS
4
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$3.53M |
| 5 |
5
Goldman Sachs
New York
|
$7.57M |
